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Abstract
Background: Public health surveillance is not ethically neutral and yet, ethics guidance and training for surveillance
programmes is sparse. Development of ethics guidance should be based on comprehensive and transparently
derived overviews of ethical issues and arguments. However, existing overviews on surveillance ethics are limited in
scope and in how transparently they derived their results. Our objective was accordingly to provide an overview of
ethical issues in public health surveillance; in addition, to list the arguments put forward with regards to arguably
the most contested issue in surveillance, that is whether to obtain informed consent.
Methods: Ethical issues were defined based on principlism. We assumed an ethical issue to arise in surveillance
when a relevant normative principle is not adequately considered or two principles come into conflict. We
searched Pubmed and Google Books for relevant publications. We analysed and synthesized the data using
qualitative content analysis.
Results: Our search strategy retrieved 525 references of which 83 were included in the analysis. We identified 86
distinct ethical issues arising in the different phases of the surveillance life-cycle. We further identified 20 distinct
conditions that make it more or less justifiable to forego informed consent procedures.
Conclusions: This is the first systematic qualitative review of ethical issues in public health surveillance resulting in
a comprehensive ethics matrix that can inform guidelines, reports, strategy papers, and educational material and
raise awareness among practitioners.
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Background
Surveillance is often referred to as the foundation or eyes
of public health [1]. The World Health Organization
(WHO) defines public health surveillance as “systematic
ongoing collection, collation and analysis of data for pub-
lic health purposes and the timely dissemination of public
health information for assessment and public health
response as necessary” [2]. Although other organizations
define surveillance slightly differently, the goal of inform-
ing public health practice is an essential element of most
definitions. Public health surveillance activities can be
differentiated along various dimensions [3]. The types of
diseases surveilled include infectious diseases as well as
non-infectious conditions like chronic diseases or risks of
negative environmental exposure to health. It can rely on
various data sources like reporting by health professionals,
health surveys or social media data, and it informs various
types of activities from education to the use of restrictive
measures.
It is important to note at the outset that public health
surveillance involves considerable ethical challenges. In
the normative and empirical literature various ethical
considerations in surveillance have been highlighted.
The fact that often surveillance data is collected without
informed consent of those affected has been addressed
frequently, provoking debates about whether this consti-
tutes an unjustified infringement of privacy or autonomy
rights although it allows the production of a more
complete and reliable data set [3–5]. Especially in the
context of HIV/AIDS, experts have warned that data
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collection strategies targeting certain vulnerable groups
or public release of data identifying high-risk groups
might lead to stigmatization and discrimination [6–8].
Although surveillance raises several ethical issues, few
government or institutional policy documents exist that
provide real-world guidance regarding how to address
these ethical challenges. Most of the normative policy
documents produced so far focus on specific disease
areas of surveillance like HIV/AIDS or occupational
health [7, 9, 10] or discuss public health projects in gen-
eralities [11, 12]. Given this existing paucity, and grow-
ing demands from different surveillance programmes,
the WHO responded by initiating a process for develop-
ing a comprehensive ethics guidance on public health
surveillance.
While scientific policy and guideline development has
been professionalized in the last decade via standards
e.g. for grading recommendations [13] or managing
conflicts of interests [14], the practice of ethics guideline
development has so far not been subject to the same
procedural and substantive standards for ensuring high
quality recommendations [15–17]. A core challenge for
the guideline developers is identifying relevant issues
and arguments [18, 19]. Ideally, guidelines should be
based on a transparent and comprehensive assessment
of ethical issues that may arise in the chosen context to
allow a rational and fair selection of issues to be ad-
dressed [20]. Furthermore, a full overview of arguments
put forward for how to handle certain issues would be
essential to ensure no important (argumentative) strat-
egies are missed. Systematic (qualitative) literature re-
views enable structured and methodologically informed
identification and synthesis of the relevant literature
with regards to pre-specified questions of interest and
can thereby assist in articulating possible issues and ar-
guments that ought to be considered and used (or expli-
citly ignored) when developing ethics guidance.
So far no systematic qualitative reviews of ethical
issues in public health surveillance have been con-
ducted. There are a few introductory book chapters
or overview articles published identifying key ethical
issues in surveillance [3, 21–23]. Furthermore, some
papers are devoted exclusively to discussing the very
prominent topic of informed consent [24, 25] with
one publication specifying certain conditions that – if
fulfilled – could justify foregoing informed consent
[5]. However, all those articles are narrative in type,
did not employ a methodology to ensure comprehen-
siveness, did not explain how they selected certain is-
sues or conditions discussed, and were generally
limited in scope due to their focus on a few particu-
lar issues or arguments.1 A systematic qualitative re-
view of ethical issues in surveillance could help fill
existing gaps.
This systematic qualitative review was undertaken to
inform the process of developing WHO guidelines on
ethical issues in public health surveillance. Accordingly,
the purpose of this systematic qualitative review was to
give a comprehensive overview of ethical issues in public
health surveillance as discussed in the academic litera-
ture. Furthermore, an additional goal was to provide a
comprehensive list of arguments raised for resolving the
seemingly most prominent issue in surveillance debates,
namely informed consent. The purpose of this review is
purely descriptive; it does not evaluate and weigh the ar-
guments raised. We abstained from further analysis as
there are no universally accepted criteria or procedures
for evaluating and synthesizing arguments as there are
for e.g. quantitative data (like GRADE [13]). The review
can only be a starting point and decision-makers will
have to implement further evaluative steps taking into
consideration the relevant contextual factors. This re-
view not only informed WHO’s guidelines, but can also
support reports, strategy papers, and educational mater-
ial on public health surveillance. It will hopefully also
raise awareness among practitioners with regards to the
variety of ethical issues they need to consider when plan-
ning, implementing, and executing public health surveil-
lance systems.
Methods
The description of methods follows the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
(short: PRISMA) Statement as far as applicable to qualita-
tive evidence syntheses [26] (see Additional file 1 for
completed PRISMA checklist). No review protocol was
published beforehand.
Inclusion criteria
For this review, we had to define two contentious terms
based on which we could formulate clear inclusion
criteria – (a) ethical issues and (b) public health surveil-
lance. Our definition of ethical issues is based on prin-
ciplism [27] which is commonly employed in bioethics
and has been used successfully in other systematic quali-
tative ethics reviews [18, 19, 28]. Most public health eth-
ics frameworks are developed in this tradition and
accordingly identify principles that are understood as
prima facie binding and action-guiding [29]. One such
framework – chosen by us because it was built on the
experience with and integrated the principles elaborated
in previously published frameworks – identifies five
guiding principles: beneficence, non-maleficence, respect
for autonomy, equity and efficiency [30]. With respect to
those principles we assume that an ethical issue arises
when (a) at least one of those principles is not adequately
considered (e.g. communities experience stigmatization by
dissemination of sensible surveillance data which would
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constitute a harm), which we referred to as risks2 or (b)
two or more of these principles are in conflict (e.g. the in-
formed consent issue: surveillance activity can only realize
public health benefit when violating the confidentiality of
medical data and thereby patient autonomy).
In contrast to other ethics reviews, we were further-
more interested in strategies for resolving issues and
therefore also extracted and categorized safeguards (de-
fined as strategies to prevent risks from materializing)
and conditions (meant as arguments raised to give one
of two conflicting principles precedence over the other);
however, those findings are not fully presented here as
the information generated was excessive for the format
of a journal publication. We will only describe our find-
ings with regards to informed consent since it is the
seemingly most contested issue.
For public health surveillance, we adopted the defin-
ition given in the introduction as formulated in the
International Health Regulations of the World Health
Organization [2] – an international point of reference.
Due to the composition of our research team, we only
included publications in English, Spanish or German.
Furthermore, publications needed to be a journal article,
book or book chapter, or a report from a governmental
institution to facilitate a rigorous and reproducible
search strategy.
Search strategy and data sources
Our search strategy was developed in cooperation with
experts of the WHO Guideline Development Group for
Ethical Issues in Public Health Surveillance. The search
was comprised of the term “ethics” and its synonyms,
terms for specific ethical issues that experts identified as
relevant in this context, as well as the term “public
health surveillance”, its synonyms and specific types of
surveillance. The search strategy for PubMed is
presented in Table 1 as required by PRISMA. The search
was conducted in February 2015. Additionally, we
searched Google Books [31] with a search string com-
bining ethics, public health surveillance and their syno-
nyms. This strategy produced more than 20,000 hits.
Due to the large number and because Google Books
sorts hits by relevance, we only included the first 100
publications. The Google Book’s sorting algorithm had
face validity as we found among the first 20 hits all im-
portant publication of which we were already aware;
upon an initial review, past the first 20 hits it seemed
that almost none of the publications applied to our
search. The Google Books search was conducted in
March 2015.
Study selection
Based on the inclusion criteria, CK and DSS screened
titles and abstracts of all articles identified via PubMed
independently. In case of disagreement, consensus was
reached discursively. As – judging from the abstract –
more or less each publication could be suspected to
potentially describe ethical issues at least as quasi-
incidental findings, we only included articles that explicitly
addressed ethical issues (as defined above). Furthermore,
CK screened the back cover descriptions and tables of
content of the Google Book’s hits and excluded those not
containing any relevant chapters. Among the hits were
also very few journal publications that were included if
Table 1 Search strategy in PubMed
Ethics 1 ethics [Mesh Terms] OR morals [Mesh Terms] OR ethic* [Title/Abstract]
2 human rights [Mesh Terms] OR “human rights” [Title/Abstract]
3 government regulation [Mesh Terms] OR regulation [Title/Abstract] OR governance [Title/Abstract]
4 1 OR 2 OR 3
Specific ethical issues 5 informed consent [Mesh Terms] OR consent [Title/Abstract]
6 “no treatment” [Title/Abstract] OR untreatable [Title/Abstract] OR incurable [Title/Abstract]
7 “follow-up care” [Title/Abstract] OR “level of care” [Title/Abstract] or “standard of care” [Title/Abstract]
8 (4 OR 5 OR 6 OR 7)
Public health surveillance 9 public health surveillance [Mesh Terms] OR “public health
surveillance” [Title/Abstract]
10 biosurveillance [Mesh Terms] OR health information systems [Mesh Terms] OR biosurveillance [Title/Abstract]
OR “disease surveillance” [Title/Abstract] OR “health information system” [Title/Abstract] OR “epidemiological
surveillance” [Title/Abstract]
11 sentinel surveillance [Mesh Terms] OR “case-based surveillance” [Title/Abstract] OR “event-based surveillance”
[Title/Abstract] OR “syndromic surveillance” [Title/Abstract] OR “sentinel surveillance” [Title/Abstract] OR
“epidemic intelligence” [Title/Abstract]
12 (9 OR 10 OR 11)
13 8 AND 12
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relevant and if they were not duplicating the PubMed
search. We then sought access via various libraries;
authors of books or book chapters were also contacted
directly to provide their manuscripts when we were un-
able to access them via our institutional libraries.
Data analysis and synthesis
The data were analysed using an adapted version of
qualitative content analysis [32]. Findings are presented
as higher- and lower-level categories in a coding frame.
The coding frame for ethical issues was developed in-
ductively from the data using the strategies of progres-
sively summarizing and subsumption [32]. Only the
highest-level codes were generated deductively for which
we used a life-cycle perspective, i.e., the natural life-cycle
of public health surveillance activities. We assumed sur-
veillance projects having broadly three phases: (a) design
and implementation, (b) data collection and analysis,
and (c) data reporting, usage and sharing. These phases
correspond with the highest-level categories. An add-
itional category “background conditions” had to be
added inductively to adequately capture our findings in
the literature and relates to the context in which surveil-
lance occurs.
The framework used to analyse the arguments raised
in relation to informed consent uses a similar approach.
The highest-level codes were again generated deduct-
ively while the rest is based on the data. One public
health ethics framework developed by Childress et al.
introduces a set of “justificatory conditions” that “are
intended to help determine whether promoting public
health warrants overriding such values as individual lib-
erty or justice in particular cases” [33] or in other words:
to support deliberations about how to resolve situations
of conflict between normative principles. We based our
analysis on this particular framework since, to the best
of our knowledge, they are the only ones who described
justificatory conditions for conflict resolution. Those
“justificatory conditions” structured the various argu-
ments raised in the literature as highest-level categories,
but had to be expanded to fit our empirical findings.
The first three authors (CK, DSS, CS) all read five arti-
cles purposefully selected (i.e., to identify as many ethical
issues as possible), extracted relevant quotes, and summa-
rized them to facilitate comparisons across our findings.
CK compared the extracted quotes and paraphrases across
reviewers and publications and constructed a preliminary
coding frame based on integration and further summariz-
ing of the findings (this strategy is called progressively
summarizing). The draft framework, underlying inter-
pretations, and further steps in the analysis and synthe-
sis were discussed during a one-day workshop with
four authors (CK, DSS, CS and DS) to increase validity
and reliability.
For the next eleven publications, the same three
authors (CK, DSS, CS) extracted relevant quotes,
checked whether the existing coding frame already de-
scribed the relevant issues, and introduced new categor-
ies where necessary (this strategy is called subsumption).
CK integrated the findings and the results were dis-
cussed during an in-person meeting. The remaining
publications were analysed by only one of the authors
(CK, DSS or CS) using again the strategy of subsump-
tion. Two further in-person meetings with all authors –
one after analysis of further 32 publications and one
after analysing the remaining 35 publications – were
convened to help resolve any remaining coding prob-
lems, and to discuss the framework’s consistency and
comprehensibility of coding formulations.
Results
Our literature search retrieved 525 publications of which
83 were finally included in the analysis and read in full
(see Fig. 1 for screening process). Three quarter of publi-
cations were journal articles (n = 65, 78%) and the
remaining were book chapters or whole books (n = 18,
22%). Articles were published between 1978 and 2014,
however, the majority was published after 2000. All pub-
lications but one were written in English. A list provid-
ing bibliographical information of all 83 publications is
available online (Additional file 2).
Ethical issues
We identified 86 distinct ethical issues in public health
surveillance. The main findings, per phase of the surveil-
lance life-cycle, include:
1. Background Conditions: generally relate to the lack,
or inappropriateness, of current guidance
frameworks used for making (normative) judgements
on surveillance systems. Additionally, it was
discussed that certain preconditions for successful
public health surveillance were not fulfilled. One
example is the lack of evidence on methods
employed in surveillance endangering the
effectiveness of such systems.
2. Design and Implementation Phase: most issues relate
to conflicts of priority setting with regards to the
type of surveillance system to be implemented and
the possibility of ill-designed systems (e.g. systems
that do not adequately consider important contextual
factors thereby reducing effectiveness). Furthermore,
necessary surveillance systems might be inadequately
or not at all implemented due to a variety of barriers
(e.g. lack of funding).
3. Data Collection and Analysis Phase: the main issues
repeatedly raised were that of privacy breaches in
data collection and storage, as well as the legitimacy
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of foregoing informed consent. In addition, the risk
of producing inappropriate data (e.g. lacking the
necessary accuracy) for public health action is
highlighted. Moreover, the worry is raised that
certain groups might be excluded from data
collection (and thereby not benefit from surveillance
activity).
4. Use of Data Phase: issues of privacy protection are
again raised, especially where data is shared with
actors outside the surveillance system. Furthermore,
the possibility of inadvertently inflicting harm (e.g.
stigmatization or discrimination) by disseminating
sensitive medical data is mentioned, as well as the
risk of foregoing benefit by not putting data to
adequate use.
Table 2 gives a fuller and detailed account of issues
discussed.
Justificatory conditions for (not) implementing informed
consent procedures
We found 20 different conditions discussed that authors
perceive to make forgoing informed consent more ethic-
ally acceptable. Again, no more than a broad overview
can be provided here: It is argued that foregoing in-
formed consent is more acceptable or justified (a) when
surveillance is effective, e.g. which can be ensured by
actually putting the data to use, (b) when it is necessary
for public health action to forego informed consent, e.g.,
because otherwise data validity is endangered, (c) when
the infringement in privacy is minimized by, e.g., collect-
ing only the minimum amount of data necessary, which
may include data anonymization, (d) when harms are
proportional to benefits, e.g., where expected benefits
are considerable, and (e) when the public is engaged in
decision-making on informed consent procedures. Those
arguments mirror the justificatory conditions described
in the public health ethics framework our work was
based on [33]. Additional codes derived inductively re-
late to (f ) protecting vulnerable populations (e.g. surveil-
lance without informed consent is acceptable to protect
the health of children), (g) making sure that only legitim-
ate institutions collect data, and (h) deploying the harm
principle or unreasonable exercise argument, which
states that collecting data from people without asking
their consent might be justified where the health of
other people needs protections, but should generally not
be considered acceptable where the purpose is to pre-
vent harm from the people being subject to surveillance
[34]. A full overview is provided in Table 3.
In the framework presenting ethical issues we intro-
duced three levels of codes (themes, codes, subcodes)
with increasing abstraction level. It would have been
possible to introduce less levels, but we found this way
of presenting our findings most accessible. In tables pro-
vided as supplemental online material we furthermore
present text examples for each ethical issue (Additional
file 3) and justificatory condition (Additional file 4)
which we will – for reasons of readability – not present
here. However, this material allows retracing the process
of synthesising the data.
Discussion
Ethical issues have to be addressed in each step of
implementing and running a public health surveillance
system. A prerequisite for dealing with ethical issues in
an adequate manner is awareness of the full spectrum
and complexity of issues that will likely arise. This re-
view therefore provides the first systematic qualitative
review of the literature for those developing guidance
Fig. 1 Flow diagram of literature screening process
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Table 2 Ethical issues in public health surveillance
Stage in the process THEMES (highest abstraction level)
Code Subcode (lowest abstraction level)
Background issues ISSUES RELATED TO CHOICE OF FRAMEWORK FOR CONDUCTING PUBLIC HEALTH SURVEILLANCE
Risk of misguided judgement due to lacking
ethical framework
Lacking ethical framework for using online data sources
Lacking ethical framework for how to treat data of the deceased
Risk of misguided judgement due to using
inappropriate ethical framework
Using research ethics framework (because criteria for differentiating
research and surveillance are missing)
Employing the research vs. practice paradigm that lacks moral
salience
Using clinical ethics framework
Using health security framework
Issues related to scientific standards for evidence
generation
Conflict between different knowledge systems
Risk of choosing framework for evidence generation that hinders
production and use of relevant data
RISK OF NOT FULFILLING PRECONDITONS FOR SUCCESSFUL PUBLIC HEALTH SURVEILLANCE
Risk of barriers hindering development of
technology to improve effectiveness and
efficiency of surveillance
Lacking funding for technology development
Lacking necessary multidisciplinary collaboration for technology
development
Risk of not producing sufficiently robust
evidence on effective surveillance methods
Issues in system design
and implementation
ISSUES OF DECIDING WHICH PUBLIC HEALTH SURVEILLANC SYSTEM SHOULD BE REALIZED
Conflicts of priority setting between different
public health programs
Prioritizing between different public health surveillance systems
Prioritizing between surveillance activity and other public health
activities
Prioritizing potential emerging threats or sustained health issues
Risk of wasting resources by prioritizing
surveillance systems
Prioritizing disease areas important for developed nations instead
of areas of high need
Prioritizing surveillance systems where other investments would
serve public health better
ISSUES OF ADEQUATELY DESIGNING A PUBLIC HEALTH SURVEILLANCE SYSTEM
Conflicts of priority setting within the design of a
surveillance program
Prioritizing comprehensiveness and accuracy of data or efficiency
of surveillance system
Prioritizing efficiency by minimizing costs or security of data
protection when employing digital technology
Prioritizing early detection of events or efficiency trough reduction
of false-positive alarms
Prioritizing maximizing amount and utility of data or security of
private information by limiting data collected
Prioritizing harmonization of methods to improve sharing
arrangements or tailoring to specific purpose
Risk of making poor choices in design of the
surveillance system
Not adequately considering equity issues in surveillance system
Not adequately tailored to the purpose and context of surveillance
Not employing health information technology and other promising
tools for improvement of surveillance activity
Not adequately coordinating and integrating surveillance initiatives
with other services – especially in developing countries
Not involving communities in development and implementation
of surveillance systems
Commissioning actors that work ineffectively, inefficiently or
unethically with running of surveillance system
Setting up surveillance systems that are inherently unsustainable,
unreliable or insensitive (without adequate safeguards in place)
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Table 2 Ethical issues in public health surveillance (Continued)
RISKS INVOLVED IN IMPLEMENTING AND RUNNING A PUBLIC HEALTH SURVEILLANCE SYSTEM
Risk of inadequate legal regulation and
governance structures for surveillance project
Inconsistent or overly complex legal guidance complicating
effective and ethical implementation – especially for projects
implemented across jurisdictions
No ethical review mechanism ensuring ethical obligations are
followed – especially for projects involving online data sources
Ethics committees making inconsistent and delayed decisions
(across jurisdictions)
Risk of barriers hindering successful
implementation or running of surveillance
system
Lacking professionals adequately trained in health information
technology
Lack of security in areas of conflict
Lacking necessary infrastructural capacity (financial,
technical,governance, human resources) - especially in developing
countries
Lacking political, societal or institutional commitment
Risk that burdens and benefits of surveillance
systems are unfairly distributed
Developing countries disproportionately burdened by international
surveillance effort
FURTHER ISSUES RELATED TO SPECIFIC KINDS OF PUBLIC HEALTH SURVEILLANCE SYSTEMS
Risks of surveillance systems relying on genetic
profiles
Surveillance activity focusing too much on genes and not enough
on other potential risk factors
Surveillance focusing on genetic profiles instead of other risk factors
plays part in shifting (too much) responsibility to the individual
Risks of real-time surveillance systems Surveillance system influences negatively the usability of electronic
medical records system other practitioners rely on
Conflicts in running vaccine safety surveillance
systems during pandemics
Conflict of prioritizing early detection of adverse events or other
effectiveness-related goals in distribution of vaccines
Issues in data collection,
analysis and storage
ISSUES OF PROTECTING AUTONOMY/THE RIGHT TO PRIVACY
Risk of people not being adequately informed about usage of their data and drop-out options – especially where data
from online sources is involved
Risk of intentional breaches of privacy/
confidentiality
Illegitimate authorities requesting data beyond what is ethically
justifiable
Individuals involved in data processing releasing data without
authorisation – especially where community members are involved in
verbal autopsy
Risk of unintentional breaches of privacy/
confidentiality
Unauthorised access through inappropriate storage and transfer of
data – especially where digital technology is used
Conflicts between obtaining informed consent (reflecting the values of confidentiality/ privacy/ respect for autonomy) and
realizing public health benefit – especially in name- or personal-identifier-based reporting
RISK OF PRODUCING INADEQUATE INFORMATION TO GUIDE PUBLIC HEALTH ACTIVITIES
Risk of collecting data that is not sufficiently
accurate or complete
Collecting incorrect/fake data from user-supplied (online) data sources
Inadequate use of electronic collection system by professionals tainting
data validity
Software errors or manipulations of electronic collection system
reducing data validity
Collecting unrepresentative data only from parts of the population
Risks of health professionals not passing on
data for analysis
Health professionals mistrusting legitimacy, usefulness and privacy of
surveillance system
Health professionals unwilling to carry administrative costs of
surveillance system (without compensation)
Risk of inadequate analysis and interpretation
of data
Gaps in evidence about subject hinder adequate interpretation
Questionable reliability of methods used for data mining and meta-
analysis
Meticulous analysis leads to harmful delays in times of emergency
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Table 2 Ethical issues in public health surveillance (Continued)
RISK OF INADEQUATELY CONSIDERING (VULNERABLE) SUBGROUPS IN DATA COLLECTION
Risk of needs of (vulnerable) subgroups not
becoming visible by inadequate data collection
strategy
Surveillance based on online data sources excludes those without
internet access
Needs of (undocumented) migrants neglected
Needs of the poorest neglected
Needs of people of colour neglected
Risk of stigmatizing subgroups by data collection
strategies that target only those subgroups
Strategies particularly targeting migrants
RISKS RELATED TO SPECIFIC DATA COLLECTION STRATEGIES
Risks related to using verbal autopsy for data
collection
Causing emotional distress in interviewees
Data produced from interviews not reliable
Risks related to using anonymous unlinked
blood testing for surveillance
Foregoing the possibility to inform people about disease and
treatment opportunities
Issues in data reporting,
sharing and using for
action
ISSUES OF ADEQUATELY PROTECTING THE RIGHT TO PRIVACY/CONFIDENTIALITY IN DATA REPORTING AND SHARING
Risk of intentional breaches of privacy/
confidentiality
Sharing data with commercial actors for their private benefit
Risk of unintentional breaches of privacy/
confidentiality
People publishing data are not adequately trained in data protection
Publicly disclosing data ensembles that allow indirect identification of
individual
Publicly quoting social media streams
Publicly releasing data that can be linked with other sources to identify
individual
Conflicts between protection of privacy/confidentiality and realizing public benefit in sharing data with actors outside the
surveillance system
ISSUES OF INFLICTING HARM OR RESTRICTING FREEDOM WHEN LABELLING INDIVIDUALS/COMMUNITIES AS SUFFERING
FROM HEALTH ISSUES
Risk of inflicting physical, social or emotional
harm
Individuals experiencing psychological adverse effects
Individuals/communities experiencing economic repercussion
Individuals/communities experiencing stigmatization and
discrimination
Physicians rejecting difficult patients to reduce problematic situations
Individuals not accessing the care they need to protect their privacy
Conflicts between protection from psychosocial
harm and realizing public health benefits
Protecting communities from stigmatization or benefiting them
through additional resource
Risk of restricting freedom of choice Individuals/communities facing coercive interventions or forms of
punishment
Conflicts between not limiting individual
freedom and realizing public health benefit
Implementing coercive interventions that benefit the targeted
individual
Implementing coercive interventions that benefit other individuals
ISSUES OF FORGOING PUBLIC HEALTH BENEFITS BY NOT ADEQUATELY PUTTING DATA TO USE
Risk of not using data (in time) for public health
action
Lacking necessary resources to act upon data
Other political interests given priority over public health goals
Risk of not sharing data with other actors National protection hinders inter-governmental sharing of data
Political interest in own visibility hinders sharing across institutions
Insufficient resources invested in data sharing arrangement
Incompatible processes for handling data hinder data sharing
Risk of not adequately communicating health
risks to public
Unintentionally not providing all relevant information for action
Deliberately communicating misleading messages for political reasons
Not finding the right level of alarm to induce adequate public reaction
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and training material, as well as public health practi-
tioners. As our target audience were practitioners and
not (foremost) the bioethics community, we found it
most helpful to use the phases of surveillance for synthe-
sising the data and not, for example, normative princi-
ples. We could thereby ground the analysis in the
practical reality of those working in the field. Our review
is furthermore different from other reviews of ethical is-
sues [18, 28] in that it also extracted proposed strategies
to adequately deal with ethical issues identified, although
we only present our findings on the issue of informed
consent. From the standpoint of guideline developers,
this broader perspective seems desirable as it allows for-
mulating recommendations regarding how to handle di-
verse issues knowing all arguments put forward in the
literature. This is the first study to demonstrate the
feasibility of such an approach. In the future, to
maximize the instrumental value for practitioners,
guideline developers, and other users of analyses of this
kind, systematic (qualitative) review approaches should
be further refined based on feedback from users.
Generally, guidelines for conducting systematic re-
views require researchers to assess the quality of the data
included [26]. However, the notion of ‘quality’ is under-
developed for ethics inquiries and we therefore refrained
from any quality assessment. This also means we did not
assess the practical relevance of ethical issues – one
promising candidate for operationalizing quality in this
context. The number of articles devoted to one issue
does not function as a reliable indicator of importance
due a number of potential limiting factors (e.g. publica-
tion bias), which was also the reason why we did not
count the number of times a particular code was dis-
cussed in the literature. Moreover, we did not address
the normative relevance of justificatory conditions intro-
duced in the literature. Decision-makers will have to
weigh the different arguments within and for their spe-
cific contexts.
Table 3 Conditions that make foregoing informed consent procedures (more) acceptable
Justificatory conditions Code (can be interpreted as specification of justificatory conditions)
Effectiveness Surveillance data is really put to use for public health purpose
Necessity Informed consent procedures reduce data validity by introducing bias
Less intrusive alternatives for collecting information not available
Implementation of informed consent procedures not feasible
Least infringement Opt-out option is provided instead
Taking data against the will of the patient is preceded by attempt of
convincing to give voluntarily (last resort)
Minimum amount of (preferably anonymized) data necessary for
surveillance purpose is collected
All relevant information about surveillance system is supplied to people
affected
Data are maintained securely to minimize further risks
Proportionality Benefit to be realized/harm averted through surveillance activity
considerable in probability and magnitude
Minimal Risks involved in data collection
Implementation of informed consent procedures would demand excessive
resources
No particularly sensitive information (e.g. mental or sexual health) is collected
Potential public health benefits outweigh considerations of privacy protection
Implementing informed consent would set harmful standards for other
surveillance programs
Public justification/engagement The community/the public/those affected were engaged in decision.
Vulnerabilitya Data is collected to protect the health of children (who need special protection)
No data from children is collected (because their privacy rights need special
protection)
Legitimacya Only legitimate entities trusted by the public collect surveillance data
Harm principles/unreasonable exercise requirementa Surveillance activity supposed to prevent harm to other individuals, not (only)
same people being surveilled
aNot contained in Childress et al.’s original list
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Nevertheless, we want to raise a few comments with
regards to the quality and breadth of the scientific dis-
course in the field of public health surveillance. First, we
found it critical that most theoretical articles we read
did not substantiate real-life risks described with empir-
ical data that could have demonstrated their relevance.
To give but one example: stigmatization as a result of
surveillance is of course a theoretical possibility, but it is
hardly discussed how often, in what setting, or for which
diseases stigmatization and discrimination are actually
experienced as a consequence of published surveillance
data. Judging from the literature we have read, the
relevant empirical literature is not adequately taken into
account in normative documents though authors’ nor-
mative arguments often rested on empirical premises.
Normative scholars in public health should therefore
make a point of considering the relevant empirical litera-
ture more explicitly.
It was furthermore noteworthy that among the publi-
cations included only one focused specifically on a low-
income country [35] and two focused on a method of
data collection (verbal autopsy) that is generally only
employed in a low-income context [36, 37]. Further-
more, five papers focused on global public health
surveillance, which actually included the low- and
middle-income countries’ perspective [38–42]. However,
the majority of articles focused on privacy in digitalized
surveillance systems, which may be of greater import-
ance in high-income countries. It seems that the
perspective of low-income countries is not well repre-
sented in the literature possibly due to preferences of re-
searchers, funding opportunities or publication bias.
However, we do not think that this is particular for the
field of surveillance research, but rather represents a
general imbalance in knowledge generation that tends to
focus on financially strong contexts. As to be expected,
there are no ready-made solutions for this problem.
Regarding the discussion of justificatory conditions, we
found it questionable that many articles stayed on a very
abstract level. Often authors just restated the – rather
abstract and broad – justificatory conditions already out-
lined in the framework of Childress et al. [33]. It is not
enough to just say that the benefits of surveillance need
to be considerable to justify foregoing informed consent,
practitioners need to know what would constitute a (in-)
considerable benefit. It would be desirable if more
authors could like Lee et al. [5] at least provide examples
(in her case HIV where limited data could lead to under-
funding of programs, increase infections and ultimately
death or so she claims) and rationales for why certain
justificatory conditions are fulfilled in a particular
context. Ethicists motivated to improve public health
practice should not shy away from more context-specific
analyses, thereby also providing example cases of
normative deliberations that practitioners will inevitably
have to address.
Lastly, we want to emphasize again that systematic re-
views can only be a starting point for any policy process.
Other types of ethical inquiry – like commissioned
evaluation of arguments or analysis of ethical issues in
novel areas – might and possibly should supplement our
research as information base for decision-making. Given
that the literature will always be limited due to personal
preferences, funding priorities and scientific paradigms,
it has been recommended [20, 43] that systematic review
findings are accompanied by hearings or surveys of
experts and possibly affected communities. This will
ensure that all important issues and arguments are
captured and discussed during guideline or further pol-
icy development.
Limitations
One limitation of this review is the inclusion of only two
databases (PubMed and Google Books). However, those
can be considered the most important ones, allowing us
to include both books and journal articles. Previous sys-
tematic reviews of medical ethics literature have shown
only marginal additional value of searching other data-
bases like EMBASE or Euroethics [19, 44]. We could
have also included additional terms to our search strat-
egy, for example, data sources for surveillance like
“screening” or “health surveys”. However, this would
have increased the number of hits for us to screen con-
siderably while promising only few additional relevant
findings. Furthermore we did not have to adapt our
matrix on the level of themes and only had to make
marginal changes on the level of codes for the last round
of analysis of the final 35 publications. We therefore as-
sumed thematic or conceptual saturation for the level of
codes, meaning that analyzing further documents would
not reveal other ethical issues at the abstraction level of
codes [45]. Due to language capacities within the re-
search team we could only include articles published in
English, German, and Spanish. However, only two papers
(one written in French [46] and one in Portuguese [47])
were excluded based on language. We are therefore
confident that we have captured the majority of issues.
One could criticize how we operationalized the funda-
mental but contested concepts that grounded our search,
first and foremost how we defined what constitutes an
ethical issue. First, we based our approach on principlism.
This lens might have complicated capturing more post-
modern or constructivist discussions and some issues that
can arguably be described as ethical will not have been
identified here. One example would be discussions that
try to clarify a particular concept – e.g. privacy rights and
their normative justification – or discussions that do not
refer to e.g. harm or autonomy violations, but more
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diffuse notions of the good to criticize certain actions.
However, we had good reasons for choosing an approach
based on principlism. Most importantly, other systematic
qualitative reviews of normative information already dem-
onstrated the instrumental value of this approach for a de-
scriptive and stakeholder-oriented analysis and synthesis
of normative arguments [18, 19, 28]. Additionally, we
found this approach to be more grounded in the actual
theoretical discussions in the public health ethics litera-
ture than, for example, an approach relying on the au-
thors’ statement in the abstract to discuss ethical issues
(which other reviews relied on [48]). Second, we also
chose one particular principlist framework over possible
alternatives [29]. It is difficult to say how choice of a differ-
ent framework might have impacted our analysis, but we
are convinced that the inclusive nature of the chosen
framework with regards to principles translated to inclu-
siveness of our research with regards to issues and argu-
ments. Further research still has to demonstrate whether
alternative approaches result in equal, superior, or inferior
results.
Additionally, systematic qualitative ethics reviews in-
volve a high level of interpretation because authors do
not always clearly describe the issues at hand, thereby
introducing a subjective or interpretive element to the
analysis on the part of those conducting the review.
However, three authors were involved in reading and
analysing the literature and met regularly to discuss
challenges with interpretations to ensure the reliability
and validity of the findings. We are therefore confident
that our interpretations properly represent the data.
Conclusion
This article gives a comprehensive overview of ethical is-
sues in public health surveillance discussed in the litera-
ture. The main findings of the review were of crucial
importance to the development of WHO’s guidelines.
While specifically helpful and important for develop-
ment of guidance documents, it can function as an in-
formation base for various actors and can also inform
the development of policies and training materials. How-
ever, we want to stress that just because this review is
conducted in a systematic and transparent fashion, fur-
ther steps will not automatically follow. There need to
be processes in place to ensure that the issues to be ad-
dressed in a guidance policy document are carefully
chosen and that recommendations are formulated in an
iterative manner taking into account many expert voices
and, preferably, of those persons ultimately affected by a
particular policy.
Assuming that systematic (qualitative) reviews will
play an increasingly important role in ethics guidance
development, it will be of importance to introduce feed-
back loops between reviewers and guideline developers.
Thereby the methodology of systematic ethics reviews
can continuously be improved and adjusted to the spe-
cific contextual needs. The same holds true for other in-
formation used in guideline development.
Endnotes
1We do not want to imply that those types of articles
are problematic. In fact we believe that context- or
issue-specific analysis can serve a vital function in
informing practitioners. The articles published so far
were, however, not sufficient as evidence base for the de-
velopment of guidelines where comprehensiveness and
systematic reduction of bias is attempted.
2We are aware that the term risk is generally used to
denote harm potential, however, this is not how it is
used here. With the introduction of the above definition
we are not making any conceptual claims with regards
to risk, but introduced the terms risk and conflict prag-
matically to delineate the two different types of ethical
issues.
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